ArticleCell biochemistry and biophysics2026
Investigating the Cellular and Tissue Response to Herbal Glucose/Cellulose-based Mesoporous Graphene Frameworks in a Rat Diabetic Wounds Model.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus represents a major global health concern, often leading to complications such as diabetic foot ulcers. Targeted therapies that leverage cellular-level mechanisms have the potential to significantly improve treatment outcomes for these ulcers, especially in severe cases such as diabetic black foot. In recent advancements, nanotechnology has emerged as a powerful tool in wound care. Aqueous Mesoporous graphene frameworks (MGFs) were developed for the first time using a graphitization and exfoliation process applied to glucosecontaining and cellulosic herbal sources. These MGFs were utilized as glucose- containing nanomaterials to promote healing in diabetic ulcers by modulating oxidative stress responses and enhancing glutathione activity in fibroblast and keratinocyte cells derived from rat models. The core processes facilitating wound repair were linked to lipid peroxidation and the release of cytochrome c, which in turn activated caspase pathways. These results underscore the promote healing candidateof MGFs in nanomedicine, particularly as next-generation formulations such as gels or powders designed for application in the diabetic and other types of chronic wounds.
Indexed as
Identifiers
41546817What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.